TY  - JOUR
T1  - SImplifying the approach to the management of dyslipidemia
AU  - Gaziano J, Gaziano TA
Y1  - 2009/11/18
N1  - 10.1001/jama.2009.1685
JO  - JAMA
SP  - 2148
EP  - 2149
VL  - 302
IS  - 19
N2  - 
In this issue of JAMA, Kuklina and colleagues1 report trends over the last decade in cholesterol levels and treatment. While the decreasing prevalence of “high” low-density lipoprotein cholesterol (LDL-C) levels and increasing use of lipid-lowering medications in appropriate individuals are encouraging, the most sobering message in this article is the disappointing rates of screening, awareness, and treatment. Among those with high LDL-C levels, one-third had not been screened, and one-fourth were unaware that their levels were high. About two-thirds of those who were high risk were not receiving medication, although the vast majority of these individuals would likely benefit from lipid-lowering therapy.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1685
UR  - http://dx.doi.org/10.1001/jama.2009.1685
ER  -